Drug Pipeline

Carvedilol Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
25
Active Studies
10
Recruiting
3
Phase 3
10
Top Sponsors
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-29 NCT07349979
PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
Primary endpoint(s) modified
2026-05-29 NCT07349979
PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF
Enrollment increased: 654 -> 1154 participants
2026-05-14 NCT06844669
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving…
Trial terminated
2026-05-14 NCT06844669
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving…
critical why stopped: null → "Futility"
Active Studies by Phase
Phase 4
8
Phase 3
2
Phase 2/3
1
Phase 2
3
Early Phase 1
1
Not specified
10
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07405944 Vericiguat and Reverse Remodeling Indices in Heart Failure Heart Failure With Reduced Ejection Fraction (HFrEF) Recruiting
NCT07521332 Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis Cirrhosis Recruiting
NCT07490067 Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol… Heart Failure With Reduced Ejection Fraction Recruiting
NCT07322237 DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With… Cirrhotic Cardiomyopathy Recruiting
NCT07352228 Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of… Rebleeding of Portal Hypertension in Liver Cirrhosis Enrolling by Invitation
NCT07298993 Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction… Heart Failure Enrolling by Invitation
NCT07295522 Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? Heart Failure Not Yet Recruiting
NCT05872698 Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial. Cirrhosis, Liver Active, Not Recruiting
Phase 3
NCT05931276 CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes End-Stage Kidney Disease Recruiting
NCT07477990 Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device… General Anxiety Disorder Recruiting
Phase 2/3
NCT06128980 Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced… Heart Failure With Reduced Ejection Fraction Recruiting
Phase 2
NCT02560805 Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV Stress Disorders, Post-Traumatic Recruiting
NCT03775096 Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136) REM Sleep Behavior Disorder Active, Not Recruiting
NCT04218968 Cardiac Changes in Early Parkinson's Disease: A Follow up Study REM Sleep Behavior Disorder Active, Not Recruiting
Early Phase 1
NCT06643221 Exercise as an Immune Adjuvant for Allogeneic Cell Therapies Leukemia Recruiting
Not specified
NCT07491718 Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy Takotsubo Cardiomyopathy Recruiting
NCT07424690 Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation Atrial Fibrillation (AF) Not Yet Recruiting
NCT07465471 Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients… Liver Cirrhosis Not Yet Recruiting
NCT06126081 Clinical Efficacy of Early Left Bundle Branch Pacing for Cardiac Resynchronization Therapy Heart Failure Active, Not Recruiting
NCT07519161 Pharmacological Intervention to Prevent NOAF After TAVR Atrial Fibrillation Not Yet Recruiting
NCT07568574 Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes Enrolling by Invitation
NCT07560982 Evaluating Adherence to Guideline-Directed Medical Therapy in Patients With Advanced… Heart Failure Not Yet Recruiting
NCT05572957 LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB Non-ischemic Cardiomyopathy Active, Not Recruiting
NCT07331220 Pulmonary Artery Denervation for Heart Failure With Preserved Left Ventricular Ejection… Heart Failure With Preserved Ejection Fraction Not Yet Recruiting
NCT07349979 PCI With GDMT Versus GDMT Alone for Patients With Ischemic Cardiomyopathy and Reduced LVEF Heart Failure With Reduced Ejection Fraction Not Yet Recruiting
Sponsors Running Carvedilol Trials
Disease Areas
Get alerts when Carvedilol trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free